Literature DB >> 18825872

Study of glucose profiles with continuous glucose monitoring in adolescents with poorly controlled type 2 diabetes mellitus.

Haiyan Lu1, Salvador Castells, Dawn Hagerty, Jose Bernardo Quintos.   

Abstract

AIM: To evaluate glycemic excursions in adolescents with poorly controlled type 2 diabetes mellitus (DM2).
METHODS: Seventeen adolescents (12 F/5 M) underwent glucose monitoring for 3 days using a continuous glucose monitoring system (CGMS). Glucose measurements were divided into periods of euglycemia, hyperglycemia, and hypoglycemia. The percentage of each period, average glucose concentration per 24 h, day and night, the number of excursions, and area under the curve (AUC) of glucose >150 mg/dl and <70 mg/dl were calculated.
RESULTS: On average, patients remained in euglycemia for 28.5%, hyperglycemia for 70%, and hypoglycemia 1.3% of the total day. Hyperglycemic excursions were more frequent during the day. Hypoglycemic events were more frequent during the night. 24-h average glucose, duration of glucose >150 mg/dl, and AUC >150 mg/dl correlate with HbA1c and fructosamine to varying degrees.
CONCLUSION: Continuous glucose monitoring provide valuable information on glucose excursions in adolescents with poorly controlled DM2 and may be helpful in improving metabolic control of poorly controlled adolescents with DM2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825872     DOI: 10.1515/jpem.2008.21.8.729

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  3 in total

1.  Clinical Use of Continuous Glucose Monitoring in Pediatrics.

Authors:  Rayhan A Lal; David M Maahs
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

Review 2.  Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes.

Authors:  Christine L Chan
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

3.  Comparison of Glycemic Excursion in Patients with New Onset Type 2 Diabetes Mellitus before and after Treatment with Repaglinide.

Authors:  Sharabeh Hezarkhani; Shokufeh Bonakdaran; Reza Rajabian; Najmeh Shahini; Abdoljalal Marjani
Journal:  Open Biochem J       Date:  2013-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.